NivolumabBullous-pemphigoid: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2026卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67135-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：272 / 272

相关论文

共 50 条

[21] NivolumabBullous pemphigoid: case report
Reactions Weekly, 2020, 1831 (1) : 229 - 229
[22] NivolumabBullous pemphigoid: case report
Reactions Weekly, 2019, 1780 (1) : 264 - 264
[23] Ipilimumab/nivolumabBullous pemphigoid: case report
Reactions Weekly, 2018, 1695 (1) : 228 - 228
[24] Ipilimumab/nivolumabBullous pemphigoid: case report
Reactions Weekly, 2019, 1769 (1) : 260 - 260
[25] Ipilimumab/nivolumabBullous pemphigoid: case report
Reactions Weekly, 2020, 1829 (1) : 221 - 221
[26] NivolumabBullous pemphigoid, thyroiditis and vitiligo: case report
Reactions Weekly, 2019, 1775 (1) : 343 - 343
[27] Doxycycline/methylprednisolone/nivolumabBullous pemphigoid and lack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 194 - 194
[28] NivolumabBullous pemphigoid: 3 case reports
Reactions Weekly, 2018, 1698 (1) : 258 - 258
[29] NivolumabBullous pemphigoid
Reactions Weekly, 2023, 1984 (1) : 402 - 402
[30] Durvalumab/nivolumabBullous pemphigoid: 3 case reports
Reactions Weekly, 2016, 1612 (1) : 80 - 80

← 1 2 3 4 5 →